Munich, Germany

Georg W Kreutzberg

This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Georg W Kreutzberg. Retrieved from https://idiyas.com/inventor/georg-w-kreutzberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Georg W Kreutzberg: Innovator in Neurotrophic Factors

Introduction

Georg W Kreutzberg is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of neurobiology, particularly in the development of neurotrophic factors. His work has implications for understanding and treating various neurological conditions.

Latest Patents

Georg W Kreutzberg holds a patent for "DNA encoding human ciliary neurotrophic factor and method for producing the protein encoded thereby." This patent represents a crucial advancement in the production of proteins that can aid in nerve cell survival and growth.

Career Highlights

Kreutzberg is associated with Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its innovative approaches to drug development. His research has been instrumental in advancing the understanding of neurotrophic factors and their therapeutic potential.

Collaborations

Throughout his career, Kreutzberg has collaborated with notable scientists, including Michael Sendtner and Kurt Stockli-Rippstein. These collaborations have enriched his research and contributed to the advancement of neurobiological studies.

Conclusion

Georg W Kreutzberg's work in neurotrophic factors and his patent contributions highlight his role as an influential inventor in the field of neurobiology. His ongoing research continues to pave the way for new therapeutic strategies in treating neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…